JBS, you assume too much on the why,
Hunter leading the P3 OA trial is sick of MSB type BM derived cells, obvious if you read up. Inconsistency. (see JCR trying to scale up your only product)
MSB is only advanced by time, not technology or patents.
In fact, they are now playing catch up on manufacturing.
JBS, you assume too much on the why,Hunter leading the P3 OA...
-
- There are more pages in this discussion • 6,475 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.150(13.0%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.33 | $1.15 | $25.26M | 19.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161000 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 50400 | 2 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |